Teva Pharmaceutical Industries Ltd (TEVA)

[genisi]

One more for TEVA- Omnicef® Capsules and Omnicef® for Oral Suspension had annual sales of approximately $325 million and $533 million, respectively, in the U.S. based on IMS sales data
Teva Gets FDA Approval for Generic Drug

http://biz.yahoo.com/ap/070510/teva_fda_approval.html?.v=1&printer=1
Thursday May 10, 11:27 am ET

Teva Gets FDA Approval for Generic Antibiotic to Treat Infections

WASHINGTON (AP) -- Teva Pharmaceutical Industries Ltd., the world's largest maker of generic drugs, said Thursday the Food and Drug Administration approved an application to market a generic antibiotic used to treat bacterial infections.

Shipments of the generic drug used to treat ear, sinus and skin infections has already started.

The Jerusalem-based company is currently involved in a patent dispute with Abbott Laboratories over the antibiotic Omnicef in federal court in northern Illinois. Abbott filed suit against Teva in March 2007.

Shares of Teva rose 12 cents to $38.45 in midday trading.